| |
| |
|
| Insider
Information: |
Akirov Alfred |
| Relationship: |
Director |
| City: |
Carmiel |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
4,915,383 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1,300,610 |
|
|
| Total
Shares |
4,915,383 |
|
|
| Total
Value |
$1,300,610 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protalix Biotherapeutics |
PLX |
Director |
|
0 |
2013-08-15 |
4,915,383 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLX |
Protalix Biotherapeutics |
Director |
– • – |
2013-08-15 |
4 |
S |
$5.07 |
$11,813 |
I/I |
(2,330) |
4,915,383 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Director |
– • – |
2013-08-14 |
4 |
S |
$5.05 |
$555,750 |
I/I |
(110,000) |
4,917,713 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Director |
– • – |
2013-03-12 |
4 |
S |
$5.70 |
$57,000 |
I/I |
(10,000) |
5,027,713 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Director |
– • – |
2013-03-11 |
4 |
S |
$5.71 |
$104,737 |
I/I |
(18,300) |
5,037,711 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Director |
– • – |
2013-03-08 |
4 |
S |
$5.82 |
$99,068 |
I/I |
(16,898) |
5,056,013 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Director |
– • – |
2013-03-07 |
4 |
S |
$5.71 |
$48,233 |
I/I |
(8,435) |
5,072,911 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Director |
– • – |
2013-03-06 |
4 |
S |
$5.68 |
$26,737 |
I/I |
(4,700) |
5,081,346 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Director |
– • – |
2008-01-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,186,046 |
|
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
